Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Onyx Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report - New Market Study Published


Print article Print article
2014-01-25 16:03:38 - Fast Market Research recommends "Onyx Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report" from MarketLine, now available

Onyx Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

This Report Features:

* Detailed information on Onyx Pharmaceuticals, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Onyx Pharmaceuticals, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Onyx Pharmaceuticals, Inc. including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and

key ratios for Onyx Pharmaceuticals, Inc.
* Intelligence on Onyx Pharmaceuticals, Inc.nv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Onyx Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/767714_onyx_pharmaceuticals_inc_swot_strateg ..

Report Highlights:

Onyx Pharmaceuticals (Onyx or 'the company') is a biopharmaceutical company engaged in the discovery and development of cancer therapies. The company primarily operates in the US, where it is headquartered in San Francisco, California. Onyx employed 420 people as of December 31, 2011. The company recorded revenues of $447.2 million during the financial year ended December 2011 (FY2011), an increase of 37.8% over FY2010. The operating profit of the company was $98.3 million in FY2011 as compared to an operating loss of $68.3 million in FY2010. The net profit was $76.1 million in FY2011, as compared to a net loss of $84.8 million in FY2010.

Reasons to Get this Report:

* Gain understanding of Onyx Pharmaceuticals, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Onyx Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Onyx Pharmaceuticals, Inc.'s business structure, strategy and prospects

Companies Mentioned in this Report: Onyx Pharmaceuticals, Inc.

Partial Table of Contents:

Company Snapshot
-Onyx Pharmaceuticals, Inc.: Company Overview
-Onyx Pharmaceuticals, Inc.: Overview and Key Facts
--Onyx Pharmaceuticals, Inc.: Overview
--Onyx Pharmaceuticals, Inc.: Key Facts
-Onyx Pharmaceuticals, Inc.: Key Employees
-Onyx Pharmaceuticals, Inc.: Key Employee Biographies
-Onyx Pharmaceuticals, Inc.: Major Products and Services
-Onyx Pharmaceuticals, Inc.: Company History
-Onyx Pharmaceuticals, Inc.: Management Statement
-Onyx Pharmaceuticals, Inc.: Key Competitors
Onyx Pharmaceuticals, Inc.: Company Analysis
-Onyx Pharmaceuticals, Inc.: Business Description
-Onyx Pharmaceuticals, Inc.: SWOT Analysis
--Onyx Pharmaceuticals, Inc.: SWOT Overview
--Onyx Pharmaceuticals, Inc.: Strengths
--Onyx Pharmaceuticals, Inc.: Weaknesses
--Onyx Pharmaceuticals, Inc.: Opportunities
--Onyx Pharmaceuticals, Inc.: Threats
-Onyx Pharmaceuticals, Inc.: Corporate Financial Deals Activity
-Onyx Pharmaceuticals, Inc.: Financial Deals Overview
-Onyx Pharmaceuticals, Inc.: Targets and Partners
-Onyx Pharmaceuticals, Inc.: Top Deals 2010 - 2014YTD*
-Onyx Pharmaceuticals, Inc.: Advisors
--Onyx Pharmaceuticals, Inc.: Top Legal Advisors
--Onyx Pharmaceuticals, Inc.: Top Financial Advisors
-Onyx Pharmaceuticals, Inc.: Capital Raising
-Onyx Pharmaceuticals, Inc.: Partnership
-Onyx Pharmaceuticals, Inc.: Private Equity and Ownership
Onyx Pharmaceuticals, Inc.: Recent Developments
-Onyx Pharmaceuticals, Inc.: News and Events Summary
-Onyx Pharmaceuticals, Inc.: Corporate Governance
-Onyx Pharmaceuticals, Inc.: Financial Performance
-Onyx Pharmaceuticals, Inc.: Regulatory and Legal Events
-Onyx Pharmaceuticals, Inc.: Research & Development
Appendix
-Contact Us
-Methodology
-Definitions
-About Datamonitor

List of Tables

Table 1: Onyx Pharmaceuticals, Inc.: Key Facts
Table 2: Onyx Pharmaceuticals, Inc.: Key Employees
Table 3: Onyx Pharmaceuticals, Inc.: Key Competitors
Table 4: Onyx Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Onyx Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2010 - YTD*2014)
Table 6: Onyx Pharmaceuticals, Inc.: Targets and Partners
Table 7: Onyx Pharmaceuticals, Inc.: Top Deals 2010 - 2014YTD*
Table 8: Onyx Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 9: Onyx Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: Onyx Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2010 - YTD*2014)
Table 11: Onyx Pharmaceuticals, Inc.: Capital Raising by Deal Type (2010 - YTD*2014)
Table 12: Onyx Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2010 - YTD*2014)
Table 13: Onyx Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2010 - YTD*2014)
Table 14: Onyx Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2010 - YTD*2014)
Table 15: Onyx Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2010 - YTD*2014)
Table 16: Onyx Pharmaceuticals, Inc.: News and Events Summary
Table 17: Onyx Pharmaceuticals, Inc.: Corporate Governance
Table 18: Onyx Pharmaceuticals, Inc.: Financial Performance
Table 19: Onyx Pharmaceuticals, Inc.: Regulatory and Legal Events

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=767714&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com